• Home
  • About
    • Overview
    • Sharing Data
    • ORCID
  • Help
  • History (74)
    • A SARS-CoV-2 protein interaction map reveals targets for drug repurposing.
    • The probate judge and involuntary civil commitment in South Carolina.
    • Neonatal urine screening for metabolic disease with auxotrophic strains of Bacillus subtilis.
    • Ceramide induces interleukin 6 gene expression in human fibroblasts.
    • AT1 receptor antagonism is proangiogenic in the brain: BDNF a novel mediator.
    • See All 74 Pages
  • search
    • Find People
    • Find Everything
Login to edit your profile (add a photo, awards, links to other websites, etc.)
  • Edit My Profile
  • My Person List (0)

AT1 receptor antagonism is proangiogenic in the brain: BDNF a novel mediator.

AT1 receptor antagonism is proangiogenic in the brain: BDNF a novel mediator. J Pharmacol Exp Ther. 2013 Feb; 344(2):348-59.

View in: PubMed

subject areas
  • Angiotensin II Type 1 Receptor Blockers
  • Animals
  • Benzimidazoles
  • Biphenyl Compounds
  • Blotting, Western
  • Brain
  • Brain-Derived Neurotrophic Factor
  • Cell Movement
  • Cell Proliferation
  • Cells, Cultured
  • Dose-Response Relationship, Drug
  • Endothelial Cells
  • Humans
  • Hypertension
  • Male
  • Neovascularization, Physiologic
  • Rats
  • Rats, Inbred SHR
  • Receptor, Angiotensin, Type 1
  • Tetrazoles

authors with profiles
  • Adviye Ergul